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14 in SVGs, 10 in right coronary arteries and 1 in a protected left main coronary artery. In 
18 pts the covered stents were implanted in de novo lesions and in 7 pts for the treatment 
of in-stent restenosis. The lesion length was 7.7 ± 5.2 mm and the stent length was 17.7 
± 6.1 mm. All pts were discharged under ticlopidine and aspirin for at least 3 months. 
Results. The procedural success rate was 100%. During hospitalization 2 pts had myo- 
cardial infarction (MI); one Q-wave and 1 non-Q-wave MI. Acute or subacute thrombosis 
was not observed. During the clinical follow-up pedod (13.1 ± 11.2 months) 2 deaths 
were encountered and one patient had Ml. Target lesion revascularization was performed 
in 8 lesions. Fourteen pts (56%) were event-free during the follow-up period. Anglo- 
graphic follow-up was performed in 15 pts after 6.1 ± 2.7 months (table). Restenosis of 
the target lesion was observed in 8 lesions (53.3%). Restenosis was focal in 7 lesions 
and diffuse in 1 lesion. The late loss was 1.8 ± 1.5 mm and the loss index was 0.7 ± 0.7. 
Conclusion. The first evaluation of PTFE-covered stents in ostial AC lesions showed that 
the incidence of angiographic and clinical restenosis remains high. 
Table Before Immediately After Follow-up 
Reference Diameter (ram) 3.50 ± 0.63 3.82 ± 0.59 3.50 ± 0.81 
Minimal Lumen Diameter (mm) 1.10 ± 0.60 3.68 ± 0.63 1.89 ± 1.32 
Stenosis (%) 69.99 ± 14.75 3.31 ± 8.72 47.89 ± 34.72 
phology before RA was significantly higher than that of non-diabetics in the follow-up 
period (41% vs 13%; p<0.05). Conclusions: We conclude that RA is not effective for 
ostial stenosis in diabetics compared with non-diabetics 
DM (n=25) Non-DM (n=30) 
ACC/AHA Type B2 19 (63%) 19 (63%) 
Type C 7 (23%) 7 (23%) 
Lesion length(mm) 9.86±7.90 9.47±8.48 
Reference (mm) 2.90±0.53 3.01±0.47 
MLD (mm) 0.86±0.39 0.95±0.44 
Before 
After 2.80±0.71 2.86±0.57 
Burr/Artery ratio 0.70±0.11 0.69±0.10 
Resenosis (%) 14/17 (61%) 9/23 (39%)* 
Progression (%) 7/17 (41%) 3/23 ( 13%)** 
*:p<0.01 **:p<0.05 
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1195MP-123 Effect  o f  Stenting on the Instantaneous Diastolic Flow 
Velocity: Pressure Gradient  Relat ion in Pat ients  With a 
Severe Coronary  Stenosis 
Koen M. Maroues, H. J. Spruijt, N. Westerhof, C. A. Visser, E C. Visser, VU Medical 
Center, Amsterdam, The Netherlands, ICarVU, Amsterdam, The Netherlands. 
In the cath lab, the significance of a coronary stanosis can be assessed by the coronary 
flow reserve (CFR) or the fractional flow reserve (FFR). Each of these techniques how- 
ever has limitations. In animals, the instantaneous diastolic flow velocity - pressure gradi- 
ent (v-dp) relation has been demonstrated to express accurately the hemodynamic 
impact of coronary stenoses. Data in humans are rare. In this study we examined the 
effect of a coronary stenosis and the effect of stenting on the v-dp - relation in 7 patients. 
A Doppler wire and a pressure wire were positioned distal to the coronary stenosis. After 
administration of adenosine the instantaneous flow velocity, the proximal and distal coro- 
nary pressure were recorded digitally (sample frequency 100Hz). For each coronary 
artery the middiastolic v-dp data of one cardiac cycle at maximal and intermediate hyper- 
emia and at baseline were plotted on an X-Y scatter plot. A regression line was calcu- 
lated using the equation: y=ax+bx 2"In all patients stanting was performed successfully. 
The mean diameter stenosis before PTCA was 70% and was reduced to 5% after stent- 
ing. The v-dp relation was reassessed after PTCA. The mean v-dp curves (± 1 SD) of all 
stenoses before PTCA and after stenting are shown in the figure. 
Conclusion: the instantaneous diastolic flow velocity - pressure gradient relation gives a 
clear quantitative description of the hemodynamic impact of a coronary stenosis in which 
both pressure and flow characteristics are incorporated. 
mean wdp relation 
. ' °  . . . .  i . . . .  i . . . .  i . . . .  i . . . . . . . . . . . . .  
i - . . . .  ,~-- -:-- - ~ ~m,==d~' ,~ . . . .  ,~ . . . .  ', . . . . .  : . . . .  7o . . . .  ', . . . .  ', . . . .  ', . . . .  " . . . .  ~ . . . .  ~- . . . .  ', . . . . .  : . . . . .  ', . . . .  
i: 
G; 70 80 90 100 0 10 20 30 4O ~0 
d~Mok flowveioclty (©rrtm¢) 
1195MP-124 
3:36 p.m. 
Comparison of Results of Rotational Atherectomy for 
Coronary Ostial Stenosis In Diabetics Versus 
Nondiabetics 
Koichi Kishi. Yoshikazu Hiasa, Koji Yamaguchi, Kensuke Fujiwara, Riyo Ogura, 
Yoshikazu Ohars, Teru Nade, Kenichiro Yuba, Kanji Kusunoki, Tatsuro Ogata, Takefumi 
Takahashi, Shinobu Hosokawa, Ryuji Otani, Tokushima Red Cross Hospital, 
Komatsushima, Japan. 
Background: The object of this study is to investigate the efficacy of rotational atherec- 
tomy (RA) for coronary artery ostial stenosis in diabetic patients.. Methods: A consecu- 
tive series of 55 patients with ostial stenosis who underwent RA were the subject of 
study. These patients were divided into diabetic and non-diabetic patients. Results: 
There were no significant differences between the two groups in terms of baseline clinical 
characteristics, lesion characteristics, and procedural factors. The restenosis rate of dia- 
betic patients was significantly higher than that of non-diabetic patients by the 6-months 
angiogram (61% vs 39%; p<0.01). The rate of progression compared with lesion mor- 
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1195MP-125 Predictors of Adverse In-Hospital Events Following 
Percutaneous Coronary Revascularization In the 
Currant Era: A Report From the NHLBI Dynamic 
Registry 
Javier Jimenez. Janet Johnston, Peter Block, Gianni Amato, Sheryl Kelsey, Howard 
Cohen, Katherine Detre, David O. Williams, Dynamic Registry Investigators, Rhode 
/s/and Hospital, Brown Universi~ Providence, Rhode/s/and. 
Background: Although stents and antithrombotic agents have enhanced the safety and 
effectiveness of percutaneous coronary intervention (PCI), in-hospital death and myocar- 
dial infarction (MI) are still observed. In an attempt to reduce the incidence of these 
adverse events further, we sought to identify those factors associated with their occur- 
rence. Methods: In-hospital outcomes and baseline and procedural characteristics were 
analyzed among 4629 patients (pts) enrolled in 17 centers within the NHLBI Dynamic 
Registry. To detect the influence of evolving therapies and techniques, patients were 
included from two enrollment waves, 1997-98 and 1999. Multivadable models were 
developed from a universe of variables potentially associated with death or death and MI. 
Results: Death occurred in 69 pts (1.5%) and death/MI in 191 pts (4.1%). Independently 
associated variables for death included total occlusion attempted (Odds Ratio 2.2, 95% 
95% Confidence Interval 1.2-4.1 ), increasing age (1.1, 1.0-1.1 ), history of CHF (2.7, 1.4- 
5.3), renal failure (3.5, 1.6-7.8), attempted vessel supplies collaterals (2.5, 1.0-6.1), car- 
diogenic shock 10.6, 4.9-22.7), >2 lesions attempted (3.0, 1.3-7.0), emergency proce- 
dure 8.9 (3.8-21.0) and urgent procedure (2.8, 1.3-6.2). When the combined endpoint of 
death/MI was analyzed, evidence of thrombus (1.8, 1.3-2.6) and peripheral vascular dis- 
ease (1.7, 1.1-2.7) were positively associated while use of ticlopidine (0.6, 0.4-0.9) had a 
protective effect. Neither stents nor planned use of Ilbllla antagonists had a protective 
effect and MI as an indication for PCI did not increase risk. Conclusion: Multiple factors 
were associated with death or death/Ml. The presence of extreme hemodynamic impair- 
ment at procedure outset was most influential while advanced age, renal failure and 
peripheral vascular disease were other contributing baseline variables. Attempting a total 
occlusion, presence of thrombus, a vessel that supplies collaterals or more than one 
lesion are variables that should be considered when selecting pts for PCI or in planning 
procedural strategies. 
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1195MP-126 Hemodynamic  Impact  of  Severe Coronary Stenoses In 
Pat ients  With and Without a Prior Myocard ia l  In farct ion  
Koen M. Maroues, H. J. Spruijt, J. G. Bronzwaer, N. Westerhof, C. A. Visser, F. C. Visser, 
VU Medical Center, Amsterdam, The Netherlands,/Car-VU, Amsterdam, The 
Netherlands. 
Background: In normal myocardial regions, the accuracy of a frectional flow reserve 
(FFR) value of 0.75 and a coronary flow velocity reserve (CFVR) value of 2.0 to identify 
significant coronary stenoses has been established. In partially infarcted regions, the 
mass of viable myocardium depending on the infarct related artery is smaller and resis- 
tive vessels may be dysfunctional; therefore it remains unknown whether the FFR and 
CFR cut-off varues are applicable in IRA's. 
Methods and Results: In this study we compared the CFVR and FFR in 6 IRA's with 
residual ischemia at SPECT MIBI with 7 IRA's without residual ischemia and 18 non- 
IRA's with ischemia. All patients in the 3 groups had a similar degree of a epicardial 
stenosis. All infarctions occurred at least 4 weeks before the measurements. The CFVR 
and FFR were measured simultaneously with a Doppler wire and a pressure wire, after 
intracoronary administration of adenosine. In contrast to the IRA's without residual 
ischemia, we found in the IRA's with residual ischemia FFR and CFVR values lower than 
the established cutoff values. 
Conclusion: these data indicate that the 0.75 and 2.0 cut-off values of FFR and CFVR 
are applicable in patients with a prior myocardial infarction. The hemodynamic impact of 
a severe coronary stenosis depends on the amount of (residual) ischemic myocardium. 
